Editorial Board — Medscape HIV/AIDS

Board Members

  • John G. Bartlett, MD
    • Johns Hopkins University School of Medicine
      The Johns Hopkins Hospital
      Baltimore, Maryland
  • Kogieleum K. Naidoo, MB ChB, PhD
    • Senior Scientist, Head of TB HIV Treatment Research Programme
      Centre for the AIDS Programme of Research in South Africa (CAPRISA)
      Nelson R. Mandela School of Medicine
      University of KwaZulu-Natal, Durban
      KwaZulu-Natal, South Africa
  • Paul E. Sax, MD
    • Harvard Medical School
      Brigham and Women's Hospital
      Boston, Massachusetts
 

Board Member Details

John G. Bartlett, MD
John G. Bartlett, MD

Professor Emeritus, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

John G. Bartlett, MD, has disclosed no relevant financial relationships.

Kogieleum K. Naidoo, MB ChB, PhD
Kogieleum K. Naidoo, MBChB

Medical Doctor, University of Natal; Head, Treatment Research Programme, Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa

Kogieleum K. Naidoo, MB ChB, PhD, has disclosed the following relevant financial relationships:
Serve(d) as executive director for: Board of Control, CAPRISA
Serve(d) as a consultant for: TB in Mines; Wits Health Consortium
Received research grant from: CDC President’s Emergency Plan for AIDS Relief; Newton Fund, South African Medical Research Council; BroadReach Healthcare/USAID; University of Cape Town; Bill & Melinda Gates Foundation; South African Medical Research Council SHIP Program

Paul E. Sax, MD
Paul E. Sax, MD

Professor of Medicine, Harvard Medical School; Clinical Director, Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts

Paul E. Sax, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: AbbVie; Bristol-Myers Squibb; Gilead; GlaxoSmithKline/ViiV; Merck; Ortho-McNeil-Janssen Pharmaceuticals, Inc
Received a research grant from: Bristol-Myers Squibb; Gilead; GlaxoSmithKline/ViiV